Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

News Daily News

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

L.A. McKeown

October 14, 2025

News Daily News

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

Caitlin E. Cox

May 19, 2025

News Conference News STS 2025

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Yael L. Maxwell

January 27, 2025

Presentation TCT 2024

TCT 875: A Multicenter Prospective Clinical Study on TAVI With the J-Valve THV for Native Pure Aortic Regurgitation: Five-Year Follow-up Outcome

Presenter: Yingqiang Guo

October 27, 2024

News Daily News

Aortic Wall Thrombus in TAVI Patients Portends Thromboembolic Events

Caitlin E. Cox

July 23, 2024

News Conference News NY Valves 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Todd Neale

June 13, 2024

Presentation NY Valves 2024

ALIGN-AR Continued Access Study Shows Positive Safety Outcomes for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation

Presenter: Raj Makkar

June 07, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Implantation for Pure Aortic Valve Regurgitation? Insights From the France-TAVI Nationwide French Registry: The PAVR Study

Presenter: Robin Le Ruz

June 07, 2024

News Conference News EuroPCR 2024

SWIFT TAVI Algorithm Lowers Wait Times for Highest-Risk Patients

Yael L. Maxwell

May 16, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Conference News PCR London Valves 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Shelley Wood

November 27, 2023

Presentation TCT 2023

TCT 414: Clinical outcomes of TAVR with an extra-large balloon-expandable valve for non-calcified aortic regurgitation: The PURE (Percutaneous Updated Managment of Aortic Regurgitartion) Study

Presenter: Ignacio Amat-Santos

October 25, 2023

News Daily News

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Yael L. Maxwell

October 20, 2023

News Conference News ACC 2023

Real-world Primary MR TEER Outcomes Carry a Reminder: Do Better

Shelley Wood

March 10, 2023

News Daily News

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

L.A. McKeown

February 17, 2023

News Features

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

Todd Neale

October 17, 2022

Presentation TCT 2022

Transcatheter Self-expanding Valve Replacement in Pure Native Aortic Regurgitation: Results from a Multicenter Registry Study

Presenter: ShaoLiang Chen

September 18, 2022

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Caitlin E. Cox

May 18, 2022

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Conference News STS 2022

Higher Mortality After MV Surgery in Poorer Communities: STS Database

Michael O'Riordan

February 02, 2022

Advertisement

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

TCT 875: A Multicenter Prospective Clinical Study on TAVI With the J-Valve THV for Native Pure Aortic Regurgitation: Five-Year Follow-up Outcome

Aortic Wall Thrombus in TAVI Patients Portends Thromboembolic Events

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

ALIGN-AR Continued Access Study Shows Positive Safety Outcomes for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation

Transcatheter Aortic Valve Implantation for Pure Aortic Valve Regurgitation? Insights From the France-TAVI Nationwide French Registry: The PAVR Study

SWIFT TAVI Algorithm Lowers Wait Times for Highest-Risk Patients

April 2024 Dispatch for the CV Team

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

TCT 414: Clinical outcomes of TAVR with an extra-large balloon-expandable valve for non-calcified aortic regurgitation: The PURE (Percutaneous Updated Managment of Aortic Regurgitartion) Study

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Real-world Primary MR TEER Outcomes Carry a Reminder: Do Better

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

Transcatheter Self-expanding Valve Replacement in Pure Native Aortic Regurgitation: Results from a Multicenter Registry Study

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Higher Mortality After MV Surgery in Poorer Communities: STS Database

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content